Orchard sells to Kyowa Kirin in gene therapy buyout
BioPharma Drive: Drug Pricing
OCTOBER 5, 2023
Kyowa will pay nearly $400 million to acquire Orchard, which sells the gene therapy Libmeldy in Europe but has struggled to find paths to market for other experimental treatments.
Let's personalize your content